Oscar Health, Inc. (OSCR) Reports Q4 Loss, Lags Revenue Estimates

Core Insights - Oscar Health, Inc. reported a quarterly loss of $0.62 per share, which was worse than the Zacks Consensus Estimate of a loss of$0.58, but an improvement from a loss of $0.66 per share a year ago [1] - The company posted revenues of$2.39 billion for the quarter ended December 2024, missing the Zacks Consensus Estimate by 2.79%, but showing significant growth from $1.43 billion year-over-year [2] - Oscar Health shares have increased approximately 24.6$0.63 on revenues of $2.8 billion, and for the current fiscal year, it is$0.77 on revenues of $11.65 billion [7] - The estimate revisions trend for Oscar Health is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Insurance - Multi line industry, to which Oscar Health belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]